{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:08:52Z","timestamp":1770070132338,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,7,9]],"date-time":"2007-07-09T00:00:00Z","timestamp":1183939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s11936-007-0028-z","type":"journal-article","created":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T22:58:49Z","timestamp":1184626729000},"page":"332-342","source":"Crossref","is-referenced-by-count":9,"title":["Optimal use of diuretics in patients with heart failure"],"prefix":"10.1007","volume":"9","author":[{"given":"Jigar","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Thomas","family":"Heywood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,9]]},"reference":[{"key":"28_CR1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","volume":"314","author":"J.N. Cohn","year":"1986","unstructured":"Cohn JN, Archibald DG, Ziesche S, et al.: Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986, 314:1547\u20131552.","journal-title":"N Engl J Med"},{"key":"28_CR2","doi-asserted-by":"crossref","unstructured":"The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group [no authors listed]. N Engl J Med 1997, 336:525\u2013533.","DOI":"10.1056\/NEJM199702203360801"},{"issue":"suppl","key":"28_CR3","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1136\/hrt.72.2_Suppl.S44","volume":"72","author":"E.B. Raftery","year":"1994","unstructured":"Raftery EB: Haemodynamic effects of diuretics in heart failure. Br Heart J 1994, 72(suppl):S44\u2013S47.","journal-title":"Br Heart J"},{"key":"28_CR4","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","volume":"100","author":"H.A. Cooper","year":"1999","unstructured":"Cooper HA, Dries DL, Davis CE, et al.: Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999, 100:1311\u20131315.","journal-title":"Circulation"},{"key":"28_CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/cs0590443","volume":"59","author":"H. Ikram","year":"1980","unstructured":"Ikram H, Chan W, Espiner EA, Nicholls MG: Haemodynamic and hormone responses to acute and chronic furosemide therapy in congestive heart failure. Clin Sci 1980, 59:443\u2013447.","journal-title":"Clin Sci"},{"key":"28_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/hrt.57.1.17","volume":"57","author":"J. Bayliss","year":"1987","unstructured":"Bayliss J, Norell M, Canepa-Anson R, et al.: Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987, 57:17\u201322.","journal-title":"Br Heart J"},{"key":"28_CR7","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.amjcard.2005.12.072","volume":"97","author":"S. Eshaghian","year":"2006","unstructured":"Eshaghian S, Horwich TB, Fonarow GC: Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 2006, 97:1759\u20131764.","journal-title":"Am J Cardiol"},{"key":"28_CR8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B. Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709\u2013717.","journal-title":"N Engl J Med"},{"key":"28_CR9","doi-asserted-by":"crossref","unstructured":"ACC\/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult\u2014Summary Article [no authors listed]. J Am Coll Cardiol 2005, 46:1116\u20131143.","DOI":"10.1016\/j.jacc.2005.08.023"},{"key":"28_CR10","volume-title":"Diuretics: Physiology, Pharmacology and Clinical Use","year":"1986","unstructured":"Dirks JH, Sutton RA, eds: Diuretics: Physiology, Pharmacology and Clinical Use. Philadelphia: W.B. Saunders Co.; 1986."},{"key":"28_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.pa.23.040183.000401","volume":"23","author":"D.C. Brater","year":"1983","unstructured":"Brater DC: Pharmacodynamic considerations in the use of diuretics. Ann Rev Pharmacol Toxicol 1983, 23:45\u201362.","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"28_CR12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1989.246","volume":"36","author":"N.R. Loon","year":"1989","unstructured":"Loon NR, Wilcox CS, Unwin RJ: Mechanism of impaired natriuretic response to furosemide during prologed therapy. Kidney Int 1989, 36:682\u2013689.","journal-title":"Kidney Int"},{"key":"28_CR13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0735-1097(03)00765-4","volume":"42","author":"M. Domanski","year":"2003","unstructured":"Domanski M, Norman J, Pitt B, et al.: Diuretic use, progressive heart failure, and death in patients in the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003, 42:705\u2013708.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2003.08.012","volume":"147","author":"J. Butler","year":"2004","unstructured":"Butler J, Forman DE, Abraham WT, et al.: Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004, 147:331\u2013338.","journal-title":"Am Heart J"},{"key":"28_CR15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/0002-9149(87)90615-1","volume":"60","author":"S.H. Kubo","year":"1987","unstructured":"Kubo SH, Clark M, Laragh JH, et al.: Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effects of upright posture and diuretics. Am J Cardiol 1987, 60:1322\u20131328.","journal-title":"Am J Cardiol"},{"key":"28_CR16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jacc.2004.04.059","volume":"44","author":"J.M. McCurley","year":"2004","unstructured":"McCurley JM, Hanlon SU, Wei S, et al.: Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol 2004, 44:1301\u20131307.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR17","first-page":"450","volume":"102","author":"C.S. Wilcox","year":"1983","unstructured":"Wilcox CS, Mitch WE, Kelly RA, et al.: Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med 1983, 102:450\u2013458.","journal-title":"J Lab Clin Med"},{"key":"28_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/A:1007835821228","volume":"13","author":"A.J. Reyes","year":"1999","unstructured":"Reyes AJ, Taylor SH: Diuretics in cardiovascular therapy: the new clinicopharm acological bases that matter. Cardiovasc Drugs Ther 1999, 13:371\u2013398.","journal-title":"Cardiovasc Drugs Ther"},{"key":"28_CR19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","volume":"57","author":"D.L. Vargo","year":"1995","unstructured":"Vargo DL, Kramer WG, Black PK, et al.: Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 1995, 57:601\u2013609.","journal-title":"Clin Pharmacol Ther"},{"key":"28_CR20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","volume":"339","author":"D.C. Brater","year":"1998","unstructured":"Brater DC: Diuretic therapy. N Engl J Med 1998, 339:387\u2013395.","journal-title":"N Engl J Med"},{"key":"28_CR21","first-page":"151","volume":"260","author":"R. Stroobandt","year":"1982","unstructured":"Stroobandt R, Dodion L, Kesteloot H: Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide. Arch Int Pharmacodyn Ther 1982, 260:151\u2013158.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"28_CR22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1388-9842(03)00150-8","volume":"5","author":"K. Muller","year":"2003","unstructured":"Muller K, Gamba G, Jaquet F, Hess B: Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV\u2014efficacy and quality of life. Eur J Heart Fail 2003, 5:793\u2013801.","journal-title":"Eur J Heart Fail"},{"key":"28_CR23","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","volume":"43","author":"B. Lopez","year":"2004","unstructured":"Lopez B, Querejeta R, Gonzalez A, et al.: Effects of loop diuretics on yocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 2004, 43:2028\u20132035.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0149-2918(99)80007-1","volume":"21","author":"L.L. Noe","year":"1999","unstructured":"Noe LL, Vreeland MG, Pezzella SM, Trotter JP: A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure. Clin Ther 1999, 21:854\u2013866.","journal-title":"Clin Ther"},{"key":"28_CR25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","volume":"96","author":"D.H. Ellison","year":"2001","unstructured":"Ellison DH: Diuretic therapy and resistance in congestive heart failure. Cardiology 2001, 96:132\u2013143.","journal-title":"Cardiology"},{"key":"28_CR26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0002-8703(75)90041-1","volume":"89","author":"B. Sigurd","year":"1975","unstructured":"Sigurd B, Olesen KH, Wennevold A: The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure: permutation trial tests in patients in long-term treatment with bumetanide. Am Heart J 1975, 89:163\u2013170.","journal-title":"Am Heart J"},{"key":"28_CR27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.7326\/0003-4819-114-10-886","volume":"114","author":"D.H. Ellison","year":"1991","unstructured":"Ellison DH: The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 1991, 114:887\u2013894.","journal-title":"Ann Intern Med"},{"key":"28_CR28","doi-asserted-by":"crossref","unstructured":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group [no authors listed]. JAMA 1991, 265:3255\u20133266.","DOI":"10.1001\/jama.1991.03460240051027"},{"key":"28_CR29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B. Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, et al.: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003, 348:1309\u20131321.","journal-title":"N Engl J Med"},{"key":"28_CR30","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"K.T. Weber","year":"1991","unstructured":"Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991, 83:1849\u20131865.","journal-title":"Circulation"},{"key":"28_CR31","doi-asserted-by":"crossref","unstructured":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). The RALES Investigators [no authors listed]. Am J Cardiol 1996, 78:902\u2013907.","DOI":"10.1016\/S0002-9149(96)00465-1"},{"key":"28_CR32","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/bmj.2.5473.1277","volume":"2","author":"J.H. Stewart","year":"1965","unstructured":"Stewart JH, Edwards KD: Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid. Br Med J 1965, 2:1277\u20131281.","journal-title":"Br Med J"},{"key":"28_CR33","first-page":"650","volume":"240","author":"M. Gasparo de","year":"1987","unstructured":"de Gasparo M, Joss U, Ramjou\u00e9 HP, et al.: Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro. J Pharmacol Exp Ther 1987, 240:650\u2013656.","journal-title":"J Pharmacol Exp Ther"},{"key":"28_CR34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mhj.2000.110933","volume":"140","author":"C. Lucas","year":"2000","unstructured":"Lucas C, Johnson W, Hamilton MA, et al.: Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 2000, 140:840\u2013847.","journal-title":"Am Heart J"},{"key":"28_CR35","first-page":"II","volume":"112","author":"J.T. Heywood","year":"2005","unstructured":"Heywood JT: Clinical predictors of worsening renal function in patients hospitalized for heart failure. Circulation 2005, 112:II\u2013589.","journal-title":"Circulation"},{"key":"28_CR36","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0735-1097(93)90405-P","volume":"22","author":"S.M. Butman","year":"1993","unstructured":"Butman SM, Ewy GA, Standen JR, et al.: Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J Am Coll Cardiol 1993, 22:968\u2013974.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1472-6963-6-30","volume":"6","author":"D.A. DeWalt","year":"2006","unstructured":"DeWalt DA, Malone RM, Bryant ME, et al.: A heart failure self-management program for patients of all literacy levels: a randomized, controlled trial [ISRCTN11535170]. BMC Health Serv Res 2006, 6:30.","journal-title":"BMC Health Serv Res"},{"key":"28_CR38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00005082-200501000-00012","volume":"20","author":"M.A. Prasun","year":"2005","unstructured":"Prasun MA, Kocheril AG, Klass PH, et al.: The effects of a sliding scale diuretic titration protocol in patients with heart failure. J Cardiovasc Nurs 2005, 20:62\u201370.","journal-title":"J Cardiovasc Nurs"},{"key":"28_CR39","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ejheart.2004.09.006","volume":"7","author":"E. Galve","year":"2005","unstructured":"Galve E, Mallol A, Catalan R, et al. Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction. Eur J Heart Fail 2005, 7:892\u2013898.","journal-title":"Eur J Heart Fail"},{"key":"28_CR40","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/oxfordjournals.eurheartj.a059535","volume":"10","author":"O. Odemuyiwa","year":"1989","unstructured":"Odemuyiwa O, Gilmartin J, Kenny D, Hall RJ: Captopril and the diuretic requirements in moderate and severe chronic heart failure. Eur Heart J 1989, 10:586\u2013590.","journal-title":"Eur Heart J"},{"key":"28_CR41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10741-005-6127-6","volume":"9","author":"G.C. Fonarow","year":"2004","unstructured":"Fonarow GC, Corday E; ADHERE Scientific Advisory Committee: Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry. Heart Fail Rev 2004, 9:179\u2013185.","journal-title":"Heart Fail Rev"},{"key":"28_CR42","unstructured":"ADHERE: Acute Decempensate Heart Failure National Registry. 1st Quarter 2006 National Benchmark Report. Available at http:\/\/www.adhereregistry.com\/nat.html Accessed February 27, 2007."},{"key":"28_CR43","doi-asserted-by":"crossref","unstructured":"Salvador DR, Rey NR, Ramos GC, Punzalan FE: Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2005, (20):CD003178.","DOI":"10.1002\/14651858.CD003178.pub3"},{"key":"28_CR44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1748-1716.1989.tb08788.x","volume":"137","author":"J. Lundvall","year":"1989","unstructured":"Lundvall J, Lanne T: Large capacity in man for effective plasma volume control in hypovolaemia via fluid transfer from tissue to blood. Acta Physiol Scand 1989, 137:513\u2013520.","journal-title":"Acta Physiol Scand"},{"key":"28_CR45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cardfail.2006.01.011","volume":"12","author":"A. Boyle","year":"2006","unstructured":"Boyle A, Sobotka PA: Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasm a refill rate. J Card Fail 2006, 12:247\u2013249.","journal-title":"J Card Fail"},{"key":"28_CR46","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","volume":"294","author":"C. Binanay","year":"2005","unstructured":"Binanay C, Califf RM, Hasselblad V, et al.: Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005, 294:1625\u20131633.","journal-title":"JAMA"},{"key":"28_CR47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","volume":"43","author":"D.E. Forman","year":"2004","unstructured":"Forman DE, Butler J, Wang Y, et al.: Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004, 43:61\u201367.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10741-005-6129-4","volume":"9","author":"J.T. Heywood","year":"2004","unstructured":"Heywood JT: The cardiorenal syndrome: lessons from the ADHERE database and treatment options. Heart Fail Rev 2004, 9:195\u2013201.","journal-title":"Heart Fail Rev"},{"key":"28_CR49","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","volume":"49","author":"M.R. Costanzo","year":"2007","unstructured":"Costanzo MR, Guglin ME, Saltzberg MT, et al.: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007, 49:675\u2013683.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR50","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jacc.2005.05.098","volume":"46","author":"B.A. Bart","year":"2005","unstructured":"Bart BA, Boyle A, Bank AJ, et al.: Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 2005, 46:2043\u20132046.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000047402","volume":"96","author":"P. Agostoni","year":"2001","unstructured":"Agostoni P, Marenzi G: Sustained benefit from ultrafiltration in moderate congestive heart failure. Cardiology 2001, 96:183\u2013189.","journal-title":"Cardiology"},{"key":"28_CR52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0002-9343(93)90119-A","volume":"94","author":"G. Marenzi","year":"1993","unstructured":"Marenzi G, Grazi S, Giraldi F, et al.: Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 1993, 94:49\u201356.","journal-title":"Am J Med"},{"key":"28_CR53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1054\/jcaf.2003.28","volume":"9","author":"B.E. Jaski","year":"2003","unstructured":"Jaski BE, Ha J, Denys BG, et al.: Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 2003, 9:227\u2013231.","journal-title":"J Card Fail"},{"key":"28_CR54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1471-4892(02)00134-0","volume":"2","author":"W.J. Welch","year":"2002","unstructured":"Welch WJ: Adenosine A1 receptor antagonists in the kidney: effects in fluid-retaining disorders. Curr Opin Pharmacol 2002, 2:165\u2013170.","journal-title":"Curr Opin Pharmacol"},{"key":"28_CR55","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.jacc.2006.08.039","volume":"48","author":"E.M. Goma de","year":"2006","unstructured":"de Goma EM, Vagelos RH, Fowler MB, Ashley EA: Emerging therapies for the management of decompensated heart failure: from bench to bedside. J Am Coll Cardiol 2006, 48:2397\u2013409.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR56","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","volume":"105","author":"S.S. Gottlieb","year":"2002","unstructured":"Gottlieb SS, Brater DC, Thomas I, et al.: BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002, 105:1348\u20131353.","journal-title":"Circulation"},{"key":"28_CR57","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1073\/pnas.92.4.1013","volume":"92","author":"S. Nielsen","year":"1995","unstructured":"Nielsen S, Chou CL, Marples D, et al.: Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A 1995, 92:1013\u20131017.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"28_CR58","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","volume":"291","author":"M. Gheorghiade","year":"2004","unstructured":"Gheorghiade M, Gattis WA, O\u2019Connor CM, et al.: Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 2004, 291:1963\u20131971.","journal-title":"JAMA"},{"key":"28_CR59","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cardfail.2005.03.009","volume":"11","author":"M. Gheorghiade","year":"2005","unstructured":"Gheorghiade M, Orlandi C, Burnett JC, et al.: Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). J Card Fail 2005, 11:260\u2013269.","journal-title":"J Card Fail"},{"key":"28_CR60","unstructured":"IvyRose Holistic: The Structure of a Kidney Nephron. Available at http:\/\/www.ivy-rose.co.uk\/Topics\/Urinary_System_Nephron_Diagram.php . Accessed on March 4, 2007."}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-007-0028-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-007-0028-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-007-0028-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:31Z","timestamp":1559422591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-007-0028-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,9]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s11936-007-0028-z","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,9]]}}}